Latest News
Latest News
News & Press
Business Achievements
- InnoCare Urologics Receives 510(k) Clearance for Its Novel Urinary Safety Catheter3 December 2024, 6:07 pm
FOR IMMEDIATE RELEASEMiami, FL -- InnoCare Urologics announced today that it has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA).InnoCare Urologics Receives 510(k) Clearance for Its...
- Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFAâ„¢ (arimoclomol) for Treatment o21 November 2024, 11:47 pm
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s...
- Venture Valuation/Biotechgate Announces Strategic Partnership with BioFlorida to Enhance USA Life Sc13 November 2024, 5:28 pm
Venture Valuation/Biotechgate Announces Strategic Partnership with BioFlorida to Enhance USA Life Sciences Database ZURICH, Switzerland, November 2024 – Biotechgate, a leading provider of life sciences information and partnering solutions, is pleased to...
- Aurita Bioscience to Launch Darcy Plate® 3D Culture System at BioFlorida Innovation Conference 202411 November 2024, 8:54 pm
Aurita Bioscience to Launch Darcy Plate® 3D Culture System at BioFlorida Innovation Conference 2024Gainesville, FL – November 11, 2024 – Aurita Bioscience, a leader in 3D cell culture solutions, is proud to announce...
- Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility25 October 2024, 1:45 am
Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility  PONTE VEDRA, Fla., Oct. 24, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company...

